Loss of genetic material in cholangiocarcinoma
Author Information
Author(s): S.-F. Ding, J.D.A. Delhanty, L. Bowles, J.S. Dooley, C.B. Wood, N.A. Habib
Primary Institution: Royal Postgraduate Medical School, Hammersmith Hospital
Hypothesis
This study investigates the loss of heterozygosity (LOH) in cholangiocarcinoma to identify potential tumor suppressor genes.
Conclusion
The study found loss of heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma for the first time.
Supporting Evidence
- Allelic losses were found in chromosomal regions 5q35-qter and 17p13.
- Overall, 164 out of 229 Southern blots were informative, showing a heterozygosity rate of 71.6%.
- 10.4% of informative cases showed loss of heterozygosity.
- Loss of heterozygosity at 5q35-qter and 17p13 may represent common genetic changes in cholangiocarcinoma and hepatocellular carcinoma.
Takeaway
Researchers looked at 14 patients with a type of cancer called cholangiocarcinoma and found that some important genes were missing from their DNA.
Methodology
The study used restriction fragment length polymorphism analysis on DNA from tumor and non-tumor tissues of patients.
Limitations
The study is limited by the small sample size and the advanced stage of cancer in patients, which may affect the ability to perform surgical resection.
Participant Demographics
All participants were patients with cholangiocarcinoma who underwent tumor resection.
Want to read the original?
Access the complete publication on the publisher's website